Kasznar Leonardos’ Marketing & Entertainment Law practice group is pleased to publish its second Advertising Law Year in Review newsletter, highlighting the … The second edition of the Advertising Law: Annual Retrospective is now available
Kasznar Leonardos is proud to be a contributor to the Legal 500’s “Brazil: Life Sciences” guide. Our partners Priscila Kashiwabara and Viviane … Kasznar Leonardos contributes to the “Brazil: Life Sciences” guide by The Legal 500
We are pleased to announce that our partners Gabriel Leonardos, Claudio Barbosa and Viviane Trojan, alongside attorneys at law Jorge Tinoco and … Chambers and Partners’ Patent Litigation Guide 2024 is now available!
Our partner Tarso Machado published an article on the FICPI – International Federation of Intellectual Property Attorneys’s website, addressing the recent modification in the patent … Tarso Machado publishes article on FICPI’s portal
The article “How to patent biological materials from 3D printing,” written by our partner Priscila Kashiwabara and patent specialist Breno Souza, has … Article “How to patent biological materials from 3D printing” for LSIPR
The chapter “Pharma & Medical Device Regulation,” authored by our partners Claudio Barbosa, Viviane Trojan and attorney at law Giovanna Mezher, has … Lexology GTDT – Pharma & Medical Device Regulation 2024
Check out the article “On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brasil”, published on IAM Media, authored by … On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brazil
Check out the article “Cannabis and IP: Nurturing innovation in Brazil’s life sciences industry”, authored by Priscila Kashiwabara and Luan Scalzitti and … Cannabis and IP: Nurturing innovation in Brazil’s Life Sciences industry
Jokes aside in the title, despite having discussed for years the possibility of registering or not the famous red sole of Louboutin … They aimed at the Louboutin sole, but hit the Osklen sneaker!
Patents to new medicines usually protect the active ingredient (compound), provided that it is new and inventive. It is also a common … “Brazil: The patent combination conundrum” for LSIPR Magazine
